To further define the point in the p38/NF-κB signal pathway at which IL-17A regulates the invasion of cervical cancer cells, we treated cervical cancer cells with SB203580(a p38 inhibitor) and PDTC(a NF-κB inhibitor), and analyzed the invasive ability. This evidence concerns the gene NFKB1 and cervical carcinoma.